<?xml version="1.0" ?>
<document id="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652">
  <chunk id="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c0" text="Citation"/>
  <chunk id="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1" text="Chemokine CXCL-8 plays a central role in human immune response by binding to and activate its cognate receptor CXCR1, a member of the G-protein coupled receptor (GPCR) family. The full-length structure of CXCR1 is modeled by combining the structures of previous NMR experiments with those from homology modeling. Molecular docking is performed to search favorable binding sites of monomeric and dimeric CXCL-8 with CXCR1 and a mutated form of it. The receptor-ligand complex is embedded into a lipid bilayer and used in multi ns molecular dynamics (MD) simulations. A multi-steps binding mode is proposed: (i) the N-loop of CXCL-8 initially binds to the N-terminal domain of receptor CXCR1 driven predominantly by electrostatic interactions; (ii) hydrophobic interactions allow the N-terminal Glu-Leu-Arg (ELR) motif of CXCL-8 to move closer to the extracellular loops of CXCR1; (iii) electrostatic interactions finally dominate the interaction between the Nterminal ELR motif of CXCL-8 and the EC-loops of CXCR1. Mutation of CXCR1 abrogates this mode of binding. The detailed binding process may help to facilitate the discovery of agonists and antagonists for rational drug design.">
    <entity charOffset="33-37" id="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e0" ontology_id="CHEBI_50906" text="role" type="chemical"/>
    <entity charOffset="494-499" id="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e1" ontology_id="CHEBI_18059" text="lipid" type="chemical"/>
    <entity charOffset="1133-1141" id="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e2" ontology_id="CHEBI_48705" text="agonists" type="chemical"/>
    <entity charOffset="1146-1157" id="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e3" ontology_id="CHEBI_48706" text="antagonists" type="chemical"/>
    <entity charOffset="1171-1175" id="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e4" ontology_id="CHEBI_23888" text="drug" type="chemical"/>
    <pair e1="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e0" e2="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e1" id="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.p0" relation="true"/>
    <pair e1="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e0" e2="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e2" id="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.p1" relation="true"/>
    <pair e1="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e0" e2="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e3" id="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.p2" relation="true"/>
    <pair e1="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e0" e2="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e4" id="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.p3" relation="true"/>
    <pair e1="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e1" e2="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e2" id="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.p4" relation="true"/>
    <pair e1="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e1" e2="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e3" id="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.p5" relation="true"/>
    <pair e1="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e1" e2="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e4" id="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.p6" relation="true"/>
    <pair e1="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e2" e2="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e3" id="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.p7" relation="true"/>
    <pair e1="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e2" e2="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e4" id="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.p8" relation="true"/>
    <pair e1="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e3" e2="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.e4" id="96c886c9234855e0fb6ef46ea3c5b7c1c7abc652.c1.p9" relation="true"/>
  </chunk>
</document>
